Table 1.

Demographic characteristics of patients with ovarian cancer

Characteristics	JARID1B expression		No. of patients (N = 120)	P
	Low	High
Age (years)				0.801
<50	13	30	43
≥50	22	55	77
Serum CA-125 level				0.43
<35	4	6	10
≥35	31	79	110
Ascites				0.9
<100	6	13	19
≥100	29	72	101
Lymph node metastasis				0.0009
Absent	31	49	80
Present	4	36	40
Histopathological differentiationa				0.0006
G1	13	11	24
G2	14	26	40
G3	8	48	56
Histology type				0.51
Serous adenocarcinoma	27	59	86
Mucoid adenocarcinoma	6	8	14
Endometrioid adenocarcinoma	2	16	18
Clear cell carcinoma	0	2	2
Residual tumor size				0.11
<1 cm	30	56	86
1–2 cm	4	18	22
≥2 cm	1	11	12
FIGO stage				0.01
I and II	5	3	8
III and IV	30	82	112
Chemotherapy regimen				0.025
TP	22	34	56
PAC	10	52	64
Chemotherapy resistance				<0.0001
Absent	32	56	88
Present	0	30	30

TP cisplatin and paclitaxel, PAC cisplatin, epirubicin, and cyclophosphamide

^aG1 is well differentiated, G2 moderately differentiated, and G3 poorly differentiated